![Hiroshi Nomura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hiroshi Nomura
Directeur/Membre du Conseil chez
SYMBIO PHARMACEUTICALS LIMITED
Profil
Actuellement, Hiroshi Nomura occupe le poste de président et directeur représentatif de Sumitomo Dainippon Pharma Co., Ltd. Il est également membre du conseil d'administration de Sunovion Pharmaceuticals, Inc, Myovant Sciences Ltd et Sumitovant Biopharma, Inc. Il a obtenu un diplôme de premier cycle à l'Université de Tokyo.
Postes actifs de Hiroshi Nomura
| Sociétés | Poste | Début |
|---|---|---|
| SYMBIO PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 24/03/2026 |
Tolero Pharmaceuticals, Inc.
 Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Directeur/Membre du Conseil | - |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Hiroshi Nomura
| Sociétés | Poste | Fin |
|---|---|---|
| SUMITOMO PHARMA CO., LTD. | Directeur Général | 25/06/2024 |
| ROIVANT SCIENCES LTD. | Directeur/Membre du Conseil | 31/08/2023 |
| MYOVANT SCIENCES LTD. | Directeur/Membre du Conseil | 22/10/2022 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Directeur Financier/CFO | 01/04/2014 |
Boston Biomedical, Inc.
 Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Directeur/Membre du Conseil | - |
Formation de Hiroshi Nomura
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
38
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Sumitomo Pharma Co., Ltd.
 Sumitomo Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and other chemical products | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anticancer drugs | Commercial Services |
Tolero Pharmaceuticals, Inc.
Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SymBio Pharmaceuticals Ltd.
 SymBio Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutics for cancer and other related diseases | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets drugs | Health Technology |
